Life-saving compound developed and patented at UToledo licensed to Prolong Pharmaceuticals

A compound developed at The University of Toledo that can be used to prevent blood vessels from leaking fluid into surrounding tissue following a traumatic injury to the human body has been licensed to Prolong Pharmaceuticals for...

Prolong Pharmaceuticals Presents Phase 1 Results For Flagship Product SANGUINATE™

SOUTH PLAINFIELD, N.J., Oct. 3, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company developing products to treat several diseases and their debilitating comorbidities presented Phase I results of its lead product, SANGUINATE™ at the...

Prolong Pharmaceuticals Presents Novel Multi-Pronged Approach To Treating Sickle Cell Disease At The SCDAA Meeting

SOUTH PLAINFIELD, N.J., Sept. 26, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemia resulting from oxygen deficiency and hemolysis, presented a novel approach...

Prolong's Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran

SOUTH PLAINFIELD, N.J., Dec. 15, 2011 /PRNewswire/ -- Prolong Pharmaceuticals today announced that Tom Flachmeyer has joined Prolong to spearhead the firms' engineering and facilities planning function for it oxygen therapeutic product SANGUINATE...

Dr. Abraham Abuchowski of Prolong Pharmaceuticals Honored With Inaugural Tibbetts Award by the U.S. Small Business Administration

SOUTH PLAINFIELD, N.J., Feb. 17, 2011 /PRNewswire/ -- Dr. Abraham Abuchowski, CEO and Scientific Founder of Prolong Pharmaceuticals, was honored by the U.S. Small Business Administration on February 15 with their inaugural Tibbetts Award for leadership...

Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team

SOUTH PLAINFIELD, N.J., Jan. 25, 2011 /PRNewswire/ -- Prolong Pharmaceuticals, which in October secured a $30 million funding commitment from a private investment group, today announced the signing of a long term lease on a manufacturing facility in South Plainfield, New Jersey and the formal addition of...

Prolong Pharmaceuticals Boosts Executive Team; Adds Industry Veterans Andy Burger, Richard Prince

SOUTH PLAINFIELD, N.J., Nov. 18, 2010 /PRNewswire/ -- Prolong Pharmaceuticals, which last month announced a $30 millionfunding commitment from a private investor group, today announced the formal addition of two pharmaceutical veterans to its senior management team...

Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President

SOUTH PLAINFIELD, N.J., Sept. 28, 2010 /PRNewswire/ -- Prolong Pharmaceuticals today announced that industry veteran Glenn Kazo has assumed the title of President. Mr. Kazo has been consulting in various capacities with Prolong since 2007. He succeeds Prolong founder Dr. Abraham Abuchowski, who remains Chief Executive Officer...

Prolong Pharmaceuticals Secures $30 Million in Funding

SOUTH PLAINFIELD, N.J., Oct. 14, 2010 /PRNewswire/ -- Prolong Pharmaceuticals today announced that the company has received a commitment of $30 million in funding from a private investor group. The monies will be...